Novo Holdings A/S 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-28 4:19 pm Sale | 2023-06-27 | 13G | Galera Therapeutics, Inc. GRTX | Novo Holdings A/S | 2,100,000 4.900% | -359,021 (-14.60%) | Filing |
| 2022-02-02 4:55 pm Sale | 2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Novo Holdings A/S | 2,459,021 9.300% | -500,000 (-16.90%) | Filing |
| 2021-02-08 4:58 pm Sale | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Novo Holdings A/S | 2,959,021 11.900% | -450,000 (-13.20%) | Filing |
| 2020-02-05 12:49 pm Unchanged | 2019-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Novo Holdings A/S | 3,409,021 13.740% | 0 (Unchanged) | Filing |